Monobenzone Topical Cream 20%

Product Description

Monobenzone 20% Cream contains Monobenzyl Ether of Hydroquinone (MBEH), a topical depigmenting agent used in the medical management of extensive vitiligo. It is prescribed for patients with widespread vitiligo who seek permanent depigmentation to achieve a more uniform skin tone.

Monobenzone works by irreversibly reducing melanin production in the skin by destroying melanocytes. Unlike temporary skin-lightening agents, Monobenzone 20% cream provides long-lasting depigmentation, making it suitable only for selected cases under strict dermatological supervision.

Key Benefits

• Used in advanced or extensive vitiligo

• Helps achieve uniform skin tone

• Permanent depigmentation therapy

• Dermatologist-prescribed topical treatment

• Pharmaceutical-grade formulation

Composition

• Active Ingredient: Monobenzone (Monobenzyl Ether of Hydroquinone) 20% w/w

• Base: Cream formulation for topical application

Indications

• Extensive vitiligo where repigmentation therapy is ineffective

• Patients opting for complete depigmentation treatment

Directions for Use

• Apply a thin layer to the affected area as directed by a dermatologist

• For external use only

• Frequency and duration depend on individual response and medical advice

Precautions & Warnings

• Prescription-only medication

• Not recommended for cosmetic or non-medical skin lightening

• Avoid sun exposure; use sunscreen as advised

• Not suitable for children, pregnant, or breastfeeding women unless prescribed

• Discontinue use if severe irritation or allergic reaction occurs

Possible Side Effects

• Skin irritation or redness

• Contact dermatitis

• Increased sensitivity to sunlight

(Consult a healthcare professional for a complete list of side effects.)

Storage Instructions

• Store below 25°C

• Keep away from direct sunlight

• Keep out of reach of children